emc receives over 40 million visits per year, with 72% of HCPs stating this resource as their first-choice source of medicines information. For a deeper look at the survey findings and its ...

In oncology care, clinical success is defined primarily by time: months or years of survival. Yet for patients living with ...

Marketing-centric engagement, designed for lower-complexity markets where scale and awareness are priorities. This model ...

ALK has announced that its EURneffy 1mg nasal adrenaline spray has received a positive opinion from the Committee for ...

What began as a convenience play has evolved into something more consequential: a shift in where trust is built; how ...

A major shift in approach is needed if patient-reported adverse events are to enable clearer safety insights and better ...

Looking across late-stage pharma R&D, three dominant themes emerge for 2026. These reflect a maturing AI landscape, ...

Whether they are navigating a tough media grilling as a crisis unfolds or translating a complex research breakthrough for a ...

Gedeon Richter UK has assumed full marketing and distribution responsibilities for the neuropsychiatry medicine cariprazine ...

Akari Therapeutics has filed a new US provisional patent covering AKTX-102, its second antibody drug conjugate targeting ...

ENA Respiratory has started dosing participants in its phase 2 community study of INNA‑051, a dry‑powder nasal spray designed to strengthen the body’s natural antiviral defences and reduce the impact ...

Ahmed Moussa has been appointed as the new Sanofi Country Lead for the UK & Ireland, taking over from Rippon Ubhi. In his new ...